These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 22429722

  • 1. Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?
    Hadji P, Gnant M, Body JJ, Bundred NJ, Brufsky A, Coleman RE, Guise TA, Lipton A, Aapro MS.
    Cancer Treat Rev; 2012 Oct; 38(6):798-806. PubMed ID: 22429722
    [Abstract] [Full Text] [Related]

  • 2. Osteoporosis risk in premenopausal women.
    Vondracek SF, Hansen LB, McDermott MT.
    Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
    [Abstract] [Full Text] [Related]

  • 3. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
    Brufsky A.
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
    [Abstract] [Full Text] [Related]

  • 4. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM, Doughty J, Eastell R, Heys SD, Howell A, McCloskey EV, Powles T, Selby P, Coleman RE.
    Cancer Treat Rev; 2008 Apr; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [Abstract] [Full Text] [Related]

  • 5. Prevention of osteoporosis after breast cancer.
    Reid DM.
    Maturitas; 2009 Sep 20; 64(1):4-8. PubMed ID: 19709826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hormone- and chemotherapy-induced bone loss in breast cancer.
    Coleman RE.
    Oncology (Williston Park); 2004 May 20; 18(5 Suppl 3):16-20. PubMed ID: 15202583
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause.
    Tham YL, Sexton K, Weiss HL, Elledge RM, Friedman LC, Kramer RM.
    J Support Oncol; 2006 Jun 20; 4(6):295-8, 304. PubMed ID: 16805332
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Lipton A.
    Breast Cancer Res Treat; 2010 Aug 20; 122(3):627-36. PubMed ID: 20490653
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.
    Candelaria-Quintana D, Dayao ZR, Royce ME.
    Breast Cancer Res Treat; 2012 Apr 20; 132(2):355-63. PubMed ID: 21987034
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Apr 20; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 18. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    Vehmanen L, Elomaa I, Blomqvist C, Saarto T.
    J Clin Oncol; 2006 Feb 01; 24(4):675-80. PubMed ID: 16446340
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010 Feb 01; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.